Please login to the form below
New Accounts, April, 2008 - Advertising
New pharmaceutical account wins notified to us by the winning agency for the period January, 2008 to March, 2008 inclusive
New pharmaceutical account wins notified to us by the winning agency for the period January, 2008 to March, 2008 inclusive
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| Baxter Healthcare UK | Brevibloc | Cardiology | WBR |
| Baxter Healthcare UK | Suprane | Anaesthesiology | WBR |
| Menarini | Migard | Migraine | Saatchi & Saatchi Healthcare |
| Sanofi Pasteur MSD | Travel vaccines portfolio | Vaccine | Woolley Pau |
| Wyeth | Prostap | Urology | Oak |
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email new_accounts@pmlive.com
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior Account Manager
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Manager
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director – UK Office
-
Excellent salary and benefits
-
Account Manager (PR)
-
Great Benefits
- FDA grants emergency authorisation to chloroquine for COVID-19
- AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance
- Novartis donates malaria drug for COVID-19 clinical trials
- Moderna and GSK advance coronavirus vaccine candidates
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Germany's coronavirus infections climb but deaths remain low
- OSE lung cancer vaccine clears phase 3 hurdle, but COVID-19 stalls programme
- Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
- UK government reveals only 2,000 key NHS staff have been tested for coronavirus
- Today’s reality: how to make social distancing work in medcomms
- Q&A: Kate Paxton
- Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs
PMHub
Red Health
Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...
Latest intelligence
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
- Pharma funding and M&A in 2020
- Why pharma M&A has continually bucked the trend...
- Behaviour change through medical education: How can we turn aspiration into reality?
- Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...
Quick links
Infographics
